Individual monitoring at accelerator facilities is discussed, within the framework set out by the International Commission on Radiological Protection and with reference to the implementation of the recommendations of that body within the European Basic Safety Standards. Legislation in other parts of the world may differ, but a worldwide perspective on this subject would be too exhaustive. The fields at accelerator facilities are contrasted in terms of particle type and energy with those encountered at more conventional sites within the nuclear fuel cycle, medical applications and general industry. The implications for individual monitoring are discussed in relation to the dose quantities for these accelerator fields and also with respect to the personal dosemeters options. Published by Oxford University Press 2011.
|Number of pages||8|
|Journal||Radiation Protection Dosimetry|
|Publication status||Published - Jul 2011|
Bibliographical noteFunding Information:
The research leading to this result received funding from the European Community’s Seventh Framework Programme FP7 within the HAMLET project under grant agreement no 218817.